Back
ADMA Biologics Vs. Greif Industry Stock Comparison
Buy
64
ADMA
ADMA Biologics
Last Price:
$18.59
Seasonality Move:
5.94%
Buy
59
GEF
Greif
Last Price:
$66.26
Seasonality Move:
0.6%
Buy
64
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
-
The current ADMA Biologics [ADMA] share price is $18.51. The Score for ADMA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
ADMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $18.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADMA is experiencing slight buying pressure.
GEF Stock Price Chart
ADMA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 46.05 | Sell |
Chaikin Money Flow: | 592928 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.65 - 20.35) | Sell |
Bollinger Bands (100): | (17.37 - 21.51) | Sell |
GEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 15.01 | Buy |
Relative Strength Index (14 RSI): | 58.21 | Buy |
Chaikin Money Flow: | -144827 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.77 - 68.01) | Buy |
Bollinger Bands (100): | (52.61 - 63.13) | Buy |
ADMA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.16 | Buy |
20-day SMA: | 18.55 | Sell |
50-day SMA: | 19.95 | Sell |
200-day SMA: | 18.9 | Sell |
8-day EMA: | 18.28 | Buy |
20-day EMA: | 18.62 | Sell |
50-day EMA: | 19.3 | Sell |
200-day EMA: | 17.95 | Buy |
GEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 68.56 | Sell |
20-day SMA: | 66.15 | Buy |
50-day SMA: | 60.54 | Buy |
200-day SMA: | 60.86 | Buy |
8-day EMA: | 42.79 | Buy |
20-day EMA: | 22.29 | Buy |
50-day EMA: | 10 | Buy |
200-day EMA: | 2.65 | Buy |
ADMA Biologics Earnings Growth & ADMA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.34 per share.
Greif Earnings Growth & GEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.38 per share, an increase next quarter of $0.80 per share, a decrease this year of $0.13 per share, and an increase next year of $1.16 per share.
ADMA Biologics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Greif Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |